search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


35 resulaten gevonden voor Novartis in trials

A national quality registry for spondyloarthritis in daily practice in the Netherlands
- TRIAL ID
NTR6740
- ACRONYMSpA-Net
A phase I/II feasibility study of the combination of panobinostat and midostaurin in recipients of allogeneic stem cell transplantation with Flt3-ITD AML
- TRIAL ID
NTR6511
- ACRONYMHOVON 148 AML
Comparison of Real-World Outcomes of 2nd Targeted Therapies in Patients with Metastatic Renal Cell Carcinoma (mRCC) Ė a Multi-Country Retrospective Chart Review
- TRIAL ID
NTR5681
- ACRONYM
De Optimal studie: Optimaliseren van Everolimus behandeling door het splitsen van innamemomenten.
- TRIAL ID
NTR4908
- ACRONYMOPTIMAL
Effects of fingolimod on advanced brain measures and clinical measures in multiple sclerosis
- TRIAL ID
NTR4657
- ACRONYM
Sandostatin therapy in sarcoidosis
- TRIAL ID
NTR4655
- ACRONYMSST in SA
Onderzoek naar kenmerken in tumorweefsel en bloed, die informatie kunnen geven over de werkzaamheid van everolimus in combinatie met exemestaan
- TRIAL ID
NTR4570
- ACRONYM
Obesity and asthma: effect of training on top of surgery
- TRIAL ID
NTR4398
- ACRONYM
Pulmonary rehabilitation and self-management in obese patients with asthma.
- TRIAL ID
NTR4322
- ACRONYMOBAS 2.1
A phase I/II feasibility study of the combination of panobinostat and decitabine prior to donor lymphocyte infusion in recipients of allogeneic stem cell transplantation with poor and very poor-risk AML
- TRIAL ID
NTR4269
- ACRONYMHOVON 116 AML
Response and Adherence to Nilotinib in Daily Practice
- TRIAL ID
NTR3992
- ACRONYMRAND-study
The development and evaluation of a new burden of disease instrument for COPD.
- TRIAL ID
NTR3788
- ACRONYMCIS
Nilotinib plus pegylated interferon alpha2b in CML.
- TRIAL ID
NTR3732
- ACRONYMNordDutchCML009
Prevalence, incidence and adherence of ďdifficult-to-treatĒ adult asthma in the Netherlands.
- TRIAL ID
NTR3546
- ACRONYM
Obesity and asthma: Effect of bariatric surgery on lung function, inflammation and quality of life.
- TRIAL ID
NTR3204
- ACRONYMOBAS
Een fase 1-2 studie van everolimus en lage dosis orale cyclofosfamide bij patiŽnten met uitgezaaide niercelkanker.
- TRIAL ID
NTR3085
- ACRONYMEverolimus-LDcyclo
Investigation on the Duration of Extended Adjuvant Letrozole treatment.
- TRIAL ID
NTR3077
- ACRONYMIDEAL
ARIA: The effects of aliskiren on albuminuria in non-diabetic nephropathy patients treated with ramipril and volume intervention.
- TRIAL ID
NTR3063
- ACRONYMARIA
A randomized phase II study for evaluation of T cell depleted non myeloablative allogeneic stem cell transplantation followed by early consolidation with lenalidomide or lenalidomide combined with bortezomib and subsequent DLI for patients with multiple myeloma in progression or relapse following first line therapy.
- TRIAL ID
NTR2958
- ACRONYMHOVON 108 MM
IJzerstapeling bij patiŽnten met MDS: De waarde van nieuwe ijzerparameters en MRI als voorspeller van ijzerstapeling.
- TRIAL ID
NTR2951
- ACRONYMPIRON01
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATION.
- TRIAL ID
NTR2545
- ACRONYMConversion from tacrolimus to everolimus in renal
Renal hemodynamic effects of aliskiren in comparison to ramipril.
- TRIAL ID
NTR2532
- ACRONYMrenal HEALTH-STudY
A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma.
- TRIAL ID
NTR2528
- ACRONYMHOVON 95 MM
Influence of everolimus on atherosclerosis in RA.
- TRIAL ID
NTR2376
- ACRONYMInfluence of everolimus on premature atherosclerosis in RA patients
Prevention and treatment of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial.
- TRIAL ID
NTR2252
- ACRONYMHOVON 96 GVHD
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetes.
- TRIAL ID
NTR2022
- ACRONYM
GLUCOVAS.
- TRIAL ID
NTR1874
- ACRONYMGLUCOVAS
A Phase II randomized multicenter study to assess the efficacy of lenalidomide with or without erythropoietin and granulocyte-colony stimulating factor in patients with low and intermediate-1 risk myelodysplastic syndrome.
- TRIAL ID
NTR1825
- ACRONYMHOVON 89 MDS
Bortezomib maintenance therapy in newly diagnosed patients with mantle cell lymphoma, responsive on rituximab combined with CHOP and high dose Ara-C and after BEAM with auto PSCT rescue.
- TRIAL ID
NTR1772
- ACRONYMHOVON 75 MCL
Fase I/II study: RAD001 and sorafenib combination in patients with advanced hcc.
- TRIAL ID
NTR1728
- ACRONYMN/A
Glivec (imatinib mesylate) in systemic sclerosis, a pilot study.
- TRIAL ID
NTR1565
- ACRONYMN/A
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II study
- TRIAL ID
NTR1461
- ACRONYMHOVON 88 CLL
Phase I/II trial of Lenalidomide plus Bortezomib combined with Dexamethasone in patients in 1st relapse or primary refractory after first line therapy for Multiple Myeloma.
- TRIAL ID
NTR1440
- ACRONYMHOVON 86 MM
Rivastigmine as a treatment in delirium; a pilot study
- TRIAL ID
NTR1395
- ACRONYMN/A
Myfortic in uveitis.
- TRIAL ID
NTR1126
- ACRONYMMyforic in Uveitis